Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Reduced paraoxonase1 activity is a risk for atherosclerosis in patients with systemic lupus erythematosus.

Annals of the New York Academy of Sciences - 1 Jun 2007

Kiss Emese, Seres Ildikó, Tarr Tünde, Kocsis Zsolt, Szegedi Gyula, Paragh György

Abstract excerpt

Excessive lipid peroxidation is a major factor of accelerated atherosclerosis, observed in patients with systemic lupus erythematosus (SLE). We aimed at the present study to determine the paraoxonasel (PON1) and arylesterase activities, and lipid-profile in 37 SLE patients and 30 age-/sex-matched...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoprotein A-I
Share to Apolipoproteins B
Share to Aryldialkylphosphatase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Atherosclerosis

Share to Carboxylic Ester Hydrolases

Share to Cholesterol, HDL

Share to Cholesterol, LDL

Share to Lipoprotein(a)

Source

Identifiers

PMID: 17893973
DOI: 10.1196/annals.1422.009

Genes

PON1
CRP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17893973-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Reduced paraoxonase1 activity is a risk for atherosclerosis in patients with systemic lupus erythematosus.PMID 17893973Read ↗

Serum Levels of Anti-PON1 and Anti-HDL Antibodies as Potential Biomarkers of Premature Atherosclerosis in Systemic Lupus Erythematosus.Semantic proximity Read ↗

Paraoxonase (PON1) 55 polymorphism and association with systemic lupus erythematosus.Semantic proximity Read ↗

Synergism between apolipoprotein E Ɛ4 allele and paraoxonase (PON1) 55-M allele is associated with risk of systemic lupus erythematosus.Semantic proximity Read ↗

Synergistic effects of BuChE non-UU phenotype and paraoxonase (PON1) 55 M allele on the risk of systemic lupus erythematosus: influence on lipid and lipoprotein metabolism and oxidative stress, preliminary report.Semantic proximity Read ↗

Systemic lupus erythematosus-accelerated atherosclerosis: mechanistic insights and clinical implications.Semantic proximity Read ↗

Relationship of serum paraoxonase 1 activity and paraoxonase 1 genotype to risk of systemic lupus erythematosus.Semantic proximity Read ↗

Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus.Semantic proximity Read ↗

Paraoxonase 1 activity and phenotype distribution in premenopausal and postmenopausal women.Semantic proximity Read ↗

PON-1 haplotype (-108C>T, L55M, and Q192R) modulates the serum levels and activity PONase promoting an atherogenic lipid profile in rheumatoid arthritis patients.Semantic proximity Read ↗

Carotid plaques in adult rheumatoid arthritis patients; association with paroxonase 1 enzymatic activity and Q192R paroxonase 1 gene polymorphism.Semantic proximity Read ↗

The Molecular Bases of Anti-oxidative and Anti-inflammatory Properties of Paraoxonase 1Semantic proximity Read ↗

Atherosclerosis and systemic lupus erythematosus — mechanistic basis of the associationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.